Orthopedic companies are developing smart implants that incorporate battery-powered sensors and self-sensing constructs to collect data and heal bones. This panel discussion includes startups and researchers who will share how they designed and developed their technologies, what data their implants track and why smart implants are critical for advancing patient care.
Product evaluation and supply chain committees are the gatekeepers of new technologies gaining entrance into hospitals. This surgeon-led session shares ways that multidisciplinary teams weigh evidence-based information on product quality and clinical data, patient safety, revenue enhancements, reimbursement considerations and more.
Additive manufacturing is now accepted as a manufacturing method for orthopedic implants, but it remains limited to one material for each printing process. This presentation will review state-of-the-art multi-metal printing, including the technical challenges, potential applications, and ways that Amnovis is advancing the technology for the orthopedic industry.
Surface finishing of joint and trauma implants is key to achieving the final performance of your products. Understanding the various finishing methods and their applications is critical because they can impact your production costs and labor needs. This session covers different surface finishing methods and how they can help you optimize your manufacturing process.
The orthopedic device industry must attract and retain employees who are engaged, feel valued and take pride in the quality of their work. Orchid has taken a project management approach to employee training and development processes at our largest manufacturing facility. This presentation reviews our efforts and the impact they’ve had on employee attraction, retention and customer service.
Head home from this session with best practices for setting expectations among supply chain partners and ways to communicate them effectively to the various stakeholders who bring predictability and operational excellence to supply chain management.
The growth in companies using additive manufacturing does not equate to an exponential increase in industry expertise and capacity. Our panel of OEMs and contract manufacturers will discuss choosing the right type of additive manufacturing for your implant, scaling your production processes and finding competent partners.
Orthopedics will see a significant transformation of the operating room, moving from a primarily analog and radiologically based set of imaging modalities to compelling new technologies like augmented reality (AR) that take advantage of rapidly developing computer-generated environments.
What initiatives are shaping the orthopedic device regulatory landscape in the United States and European Union? OSMA representatives will discuss FDA's stance on MR labeling & testing and biocompatibility. They'll also offer insight from Notified Bodies on the EU MDR implementation.
ASCs are primed to capture more business if they keep pace with increasing caseloads and invest in new technologies that help surgeons achieve positive outcomes. Experts in the field come together to provide their perspectives on how OEMs must shift their product development focus.
Learn what great teaming is, the phases required to achieve it and a clear roadmap for creating a cohesive effort across various functions. You will come away with a clear framework, useful tools and an action plan to get the most out of your team.
This panel discussion includes orthopedic companies with varying types of enabling and digital technologies. The group will explore questions such as: What are the uses and benefits of the technology today? How will the technology advance over time? How will data be captured and utilized to improve technology, surgical techniques and patient outcomes? What will it take to gain greater adoption in orthopedics?
